Cryo-Save Group N.V. - Share buyback tranche successfully completed

Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces that it has completed the tranche of its share buyback programme as announced on 30 January 2013. The Group has purchased 1,597 shares and has reached an agreement with a shareholder regarding the buyback of 120,000 shares via its bank Kempen & Co. The share purchase and the block trade are part of the share buyback programme as announced yesterday. Cryo-Save repurchased these 121,597 shares at an average price of € 2.34. These shares together with the 364,000 treasury shares that are already in the possession of the Group, representing 5% of the issued shares, will be proposed for cancellation by the Board at the upcoming Annual General Meeting on 15 May 2013. Enquiries: Cryo-Save Group, Arnoud van Tulder, Chief Executive Officer + 31 (0) 575 509 100 Please click here for full press release in PDF: This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Cryo-Save Group N.V. via Thomson Reuters ONE [HUG#1674596]